References

References

Brufsky A and Mathew A (2015) Bisphosphonates, bone, and breast cancer recurrence. Lancet 386: 1319–20

Coleman R, Cameron D, Dodwell D et al. (2014) Adjuvant zoledronic acid in patients with early breast cancer: Final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial. Lancet Oncology 15(9): 997–1006

Dhesy-Thind S, Fletcher GG, Blanchette PS et al (2017) Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology 35: 2062–81

Early Breast Cancer Trialists' Collaborative Group (2015) Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet 386: 1353–61

Gnant M, Mlineritsch B, Stoeger H et al. (2015) Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: Final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12. Annals of Oncology 26(2): 313–20

Gralow J, Barlow WE, Alexander HG et al. (2015) Phase III Trial of Bisphosphonates as Adjuvant Therapy in Primary Breast Cancer: SWOG/Alliance/ECOG-ACRIN/NCIC Clinical Trials Group/NRG Oncology Study S0307. Journal of Clinical Oncology 33 (suppl; abstr 503)

Hadji P, Coleman RE, Wilson C et al. (2016) Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel. Annals of Oncology 27(3): 379–90

Jacobs C, Amir E, Paterson A et al. (2015) Are adjuvant bisphosphonates now standard of care of women with early stage breast cancer? A debate from the Canadian Bone and the Oncologist New Updates meeting. Journal of Bone Oncology 4(2): 54–8

Tierney JF, Vale C, Riley R, Smith CT, Stewart L, Clarke M, et al. (2015) Individual participant data (IPD) meta-analyses of randomised controlled trials: guidance on their use. PLoS Med 12(7): e1001855

Wong MHF, Stockler MR and Pavlakis N. Bisphosphonates and other bone agents for breast cancer. Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD003474. DOI: 10.1002/14651858.CD003474.pub3